Login

ARRAY BIOPHARMA INC SEC Filings

Filed On Filing
14 Feb 2020 SC 13G/A
12 Aug 2019 SC 13G/A
09 Aug 2019 15-12B
31 Jul 2019 EFFECT
31 Jul 2019 EFFECT
31 Jul 2019 EFFECT
31 Jul 2019 EFFECT
31 Jul 2019 EFFECT
31 Jul 2019 EFFECT
31 Jul 2019 EFFECT
31 Jul 2019 EFFECT
31 Jul 2019 EFFECT
31 Jul 2019 EFFECT
31 Jul 2019 EFFECT
31 Jul 2019 EFFECT
30 Jul 2019 Form 4: Van Lunsen Gil J, Director

Returned 29,297 shares to the issuer · Disposed of 50,000 Stock Option (Right to Buy) (Disposition to Issuer)

30 Jul 2019 Form 4: Squarer Ron, Director

Returned 702,081 shares to the issuer · Disposed of 3,158,945 Stock Option (Right to Buy) (Disposition to Issuer)

30 Jul 2019 Form 4: Sharp Shalini, Director

Returned 10,000 shares to the issuer · Disposed of 75,000 Stock Option (Right to Buy) (Disposition to Issuer)

30 Jul 2019 Form 4: Sandor Victor, Chief Medical Officer

Returned 324,364 shares to the issuer · Disposed of 1,124,828 Stock Option (Right to Buy) (Disposition to Issuer)

30 Jul 2019 Form 4: Saccomano Nicholas A, CSO

Returned 212,003 shares to the issuer · Disposed of 684,750 Stock Option (Right to Buy) (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support